Elena Lam’s Post

#Emergency_Medical_Service (EMS) System Market Foresees a Substantial Revenue Surge from 2023 to 2032 https://lnkd.in/dAED4Jdg The growing number of #hospitals and increasing #funds and investments in service is likely to accelerate the emergency #medical service (EMS) system market during the #forecast period. Across the globe, emergency #medical services have #developed an extended role with #medical emergencies utilizing advanced clinical #technology contributing to the overall function of #health care systems. Medtronic Medtronic Diabetes GE Centurion Medical Products Boston Scientific en Costa Rica Terumo Corporation Johnson Service Group, Inc. 3M Smith+Nephew C. R. Bard GmbH DiagMed Convatec Convatec Infusion Care Baxter International Inc. BKK B. Braun Melsungen AG

Respiratory Diagnostics Market worth $8.2 billion by 2029 Download PDF Brochure:-https://lnkd.in/dTA3Wg-Y The global size of respiratory diagnostics market in terms of revenue was estimated to be worth $5.6 billion in 2023 and is poised to reach $8.2 billion by 2029, growing at a CAGR of 6.6% from 2023 to 2029. 𝐓𝐡𝐞 𝐜𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬 𝐟𝐞𝐚𝐭𝐮𝐫𝐞𝐝 𝐢𝐧 𝐭𝐡𝐢𝐬 𝐫𝐞𝐩𝐨𝐫𝐭 𝐢𝐧𝐜𝐥𝐮𝐝𝐞 Koninklijke Kentalis BD Abbott Thermo Fisher Scientific GE HealthCare Bio-Rad Laboratories, bioMérieux Revvity, Seegene Inc. Nihon Kohden America Vitalograph SDI Diagnostics ResMed Siemens Healthcare FZ LLC COSMED USA Hologic, Inc. QIAGEN Vyaire Medical Visby Medical, Briota Technologies Bird Healthcare Löwenstein Medical ProAxsis ndd Medical Technologies Compumedics USA, LLC 𝐎𝐭𝐡𝐞𝐫 𝐜𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬 𝐭𝐡𝐚𝐭 𝐚𝐫𝐞 𝐨𝐩𝐞𝐫𝐚𝐭𝐢𝐧𝐠 𝐢𝐧 𝐭𝐡𝐢𝐬 𝐦𝐚𝐫𝐤𝐞𝐭 𝐠𝐥𝐨𝐛𝐚𝐥𝐥𝐲 Smiths Medical Teleflex Medtronic Masimo Cardinal Health Drägerwerk AG & Co. KGaA HILL-ROM UK (HOLDINGS) LTD, Mindray Fisher & Paykel Healthcare Invacare Corporation OMRON Healthcare, Inc. Philips Inogen. Getinge Breas Medical #respiratorydiagnostics #pulmonaryhealth #lungfunction #medicaldevices #breathingsolutions

Respiratory Devices Accessories Market Analysis Report 2023: Segments, Share, Regulatory, Reimbursement, and Forecast to 2033 - ResearchAndMarkets.com DUBLIN--(BUSINESS WIRE)--The "Respiratory Devices Accessories Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2033" report has been added to ResearchAndMarkets.com's offering. Respiratory Device Accessories Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2033 is built to visualize quantitative market trends within Anesthesia and Respiratory Devices therapeutic area. The model discusses in detail the impact of COVID-19 on Respiratory Devices. via Business Wire Health: Medical Devices News

OMRON Healthcare EMEA India has announced a strategic collaboration with AliveCor India, marking its #entry into the realm of cardiovascular monitoring beyond its existing expertise in #bloodpressure monitoring. Through this partnership, OMRON Group introduces AI-based handheld #ECG (Electrocardiogram) technology, complementing its range of #healthcare solutions in India. The collaboration introduces a range of cutting-edge devices, including a home BPM+ECG #monitoring device that combines a blood pressure monitor with #AliveCor #ECG capability in a single device. This FDA-cleared device aims to facilitate early detection and management of CardioVascular Disease (CVD). Additionally, AliveCor’s FDA-cleared pocket-sized personal ECGs are also part of the offering, enabling instant #detection of various arrhythmias, including atrial fibrillation (Afib), #bradycardia, and #tachycardia. Tetsuya Yamada, MD of OMRON Group, highlights the importance of monitoring both ECG and blood pressure at home for the early management of cardiovascular and cerebrovascular #healthconditions like stroke. He emphasizes that early detection is crucial, especially considering the significantly heightened stroke risk associated with conditions such as Afib. Yamada further elaborates on the collaboration, stating that the innovative devices aim to reduce the waiting period for ECG measurement and enhance accessibility. This, in turn, #empowers patients to keep their doctors and caregivers informed in real-time, facilitating more informed decision-making for cardiovascular #healthmanagement. Anuj Seth, MD of AliveCor, expresses excitement about the partnership with Omron, emphasizing the opportunity to extend the reach of their products to more patients, thereby potentially saving more lives. The collaboration between Omron and AliveCor signifies a significant step forward in empowering individuals to proactively monitor their cardiovascular health and underscores the importance of accessible and convenient healthcare solutions in combating cardiovascular diseases. https://lnkd.in/gmPgeTdx #News #Medlr #Healthnews #Healthcare #Health

In the realm of diabetic care, quality is not just a feature; it's a necessity. Recognizing this critical need, APS America has risen to the challenge, setting new benchmarks in lancet manufacturing. Our lancets aren't merely produced; they're crafted with a commitment to excellence. Each lancet passes through stringent quality checks, ensuring they not only meet but exceed the highest standards in healthcare. This rigorous process is our way of providing you with more than a tool – it's giving you a piece of mind, a confidence that comes with knowing you're using a product synonymous with quality and reliability. For APS America, quality is not a mere claim; it's an enduring promise. A promise that every prick is backed by precision engineering, advanced technology, and an unwavering dedication to excellence. Step Up to Superior Quality with APS America. For lancets that embody excellence in every aspect, contact Shun Mimura at APS America. Reach out at +1-678-601-5370 or email [email protected]. Visit our new site: https://lnkd.in/e6TTy-uX #QualityFirst #APSExcellence #ReliableDiabeticCare #HealthcareInnovation #APSStandard Becton, Dickinson and Company Roche Diagnostics Polska Abbott Laboratories Executive Medtronic Johnson & Johnson Bayer HealthCare Diabetes Care Thermo Fisher Scientific Siemens Healthineers Owen Mumford Terumo Medical Corporation

The RSSDI - Research Society for the Study of Diabetes in India (RSSDI) and the Koita Foundation have forged a strategic partnership to inaugurate the RSSDI-Koita Centre for Digital Diabetology (KCDD). This collaboration aims to advance #diabetesmanagement and research through innovative digital solutions. The Memorandum of Understanding (#MoU) was formalized in the presence of esteemed dignitaries including Dr. Rakesh Sahay, President of RSSDI, Dr. Sanjay Agarwal, #SecretaryGeneral of RSSDI, Rekha Koita, Director of Koita Foundation, and Surabhi Goel, Chief Operating Officer of Koita Foundation. The signing ceremony took place during the RSSDI - Research Society for the Study of Diabetes in India Annual Research Retreat 2024 in Jaipur on April 13, 2024. RSSDI is the largest association of physicians dedicated to diabetes care in Asia, boasting over 11,500 members across 23 states in India. On the other hand, the Koita Foundation is a non-profit organization committed to advancing digital health adoption and NGO transformation in India. RSSDI-KCDD marks a pioneering endeavor in digital diabetology, aiming to leverage technology to enhance various aspects of diabetes care: Quality Improvement: Utilizing digital tools such as Electronic Medical Records (EMRs) and artificial intelligence (AI) to enhance treatment workflows, patient engagement, and adherence to clinical guidelines. Affordability: Identifying opportunities for cost reduction through data sharing and technology adoption to make diabetes care more accessible and affordable. Access Enhancement: Leveraging telemedicine and digital solutions to improve access to high-quality diabetes care, especially in rural and non-urban areas. Productivity Enhancement: Streamlining clinical and administrative workflows through digital automation to boost efficiency and reduce manual tasks. Best Practices: Identifying and disseminating best practices in digital technology for diabetes management. Training and Capacity Building: Providing continuous learning opportunities and skill development for healthcare professionals through digital platforms. Research and Development: Collaborating with healthcare startups, pharmaceutical companies, and other organizations to drive research and development initiatives in diabetes care. Dr. Rakesh Sahay emphasized the significance of this initiative in advancing diabetes care management, particularly in addressing challenges related to timely and accurate patient data. Dr. Sanjay Agarwal underscored the importance of leveraging digital tools to support patients, healthcare professionals, and systems. #News #Medlr #Healthnews #Healthcare #Health

Rising incidence of chronic diseases, increasing advancements in #syringe_pump_technology, and growing trend towards home-based healthcare services are projected to propel the expansion of the global #𝐬𝐲𝐫𝐢𝐧𝐠𝐞_𝐩𝐮𝐦𝐩_𝐦𝐚𝐫𝐤𝐞𝐭 during the #forecast period between 2023 and 2029. 🌐𝐑𝐞𝐪𝐮𝐞𝐬𝐭 𝐟𝐨𝐫 𝐭𝐡𝐞 𝐒𝐚𝐦𝐩𝐥𝐞 𝐂𝐨𝐩𝐲: https://lnkd.in/dvezKvvN ▶ 𝐊𝐞𝐲 𝐏𝐥𝐚𝐲𝐞𝐫𝐬: ✔ BD ✔ Baxter International Inc. ✔ Medtronic ✔ Fresenius Kabi ✔ Terumo Medical Corporation ✔ Smiths Medical ✔ Moog Inc., ✔ B. Braun Group, ✔ Hospira, ✔ Nipro Medical Corporation, ✔ Mindray, ✔ Roche Diagnostics USA, ✔ Zyno Medical, ✔ Nikkiso Cosmodyne. 📣 𝐌𝐚𝐫𝐤𝐞𝐭 𝐁𝐲 𝐄𝐧𝐝 𝐔𝐬𝐞𝐫: Based on end user, the global syringe pump market is bifurcated into Hospitals & Clinics and Ambulatory Care Settings segments. The hospitals and clinics segment holds a #higher_share in the market due to the continuous demand for syringe pumps in these #healthcare settings. #Hospitals and clinics are major healthcare providers where #syringe_pumps are extensively used for precise drug delivery and fluid administration. #BlueWeave #marketresearch #medcialdevices #healthcareindustry #healthcaretechnology

Rising incidence of chronic diseases, increasing advancements in #syringe_pump_technology, and growing trend towards home-based healthcare services are projected to propel the expansion of the global #𝐬𝐲𝐫𝐢𝐧𝐠𝐞_𝐩𝐮𝐦𝐩_𝐦𝐚𝐫𝐤𝐞𝐭 during the #forecast period between 2023 and 2029. 🌐𝐑𝐞𝐪𝐮𝐞𝐬𝐭 𝐟𝐨𝐫 𝐭𝐡𝐞 𝐒𝐚𝐦𝐩𝐥𝐞 𝐂𝐨𝐩𝐲: https://lnkd.in/dvezKvvN ▶ 𝐊𝐞𝐲 𝐏𝐥𝐚𝐲𝐞𝐫𝐬: ✔ BD ✔ Baxter International Inc. ✔ Medtronic ✔ Fresenius Kabi ✔ Terumo Medical Corporation ✔ Smiths Medical ✔ Moog Inc., ✔ B. Braun Group, ✔ Hospira, ✔ Nipro Medical Corporation, ✔ Mindray, ✔ Roche Diagnostics USA, ✔ Zyno Medical, ✔ Nikkiso Cosmodyne. 📣 𝐌𝐚𝐫𝐤𝐞𝐭 𝐁𝐲 𝐄𝐧𝐝 𝐔𝐬𝐞𝐫: Based on end user, the global syringe pump market is bifurcated into Hospitals & Clinics and Ambulatory Care Settings segments. The hospitals and clinics segment holds a #higher_share in the market due to the continuous demand for syringe pumps in these #healthcare settings. #Hospitals and clinics are major healthcare providers where #syringe_pumps are extensively used for precise drug delivery and fluid administration. #BlueWeave #marketresearch #medcialdevices #healthcareindustry #healthcaretechnology

𝗥𝗲𝘀𝗽𝗶𝗿𝗮𝘁𝗼𝗿𝘆 𝗖𝗮𝗿𝗲 𝗗𝗲𝘃𝗶𝗰𝗲𝘀 𝗠𝗮𝗿𝗸𝗲𝘁 𝗚𝗿𝗼𝘄𝘁𝗵 𝗖𝗮𝗽𝗽𝗲𝗱 𝗮𝘁 7.8% 𝗖𝗔𝗚𝗥 𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐏𝐃𝐅 𝐁𝐫𝐨𝐜𝐡𝐮𝐫𝐞: https://lnkd.in/dSh6Up2q The global respiratory care devices market in terms of revenue was estimated to be worth $21.8 billion in 2023 and is poised to reach $31.8 billion by 2028, growing at a CAGR of 7.8% from 2023 to 2028. 𝐎𝐩𝐩𝐨𝐫𝐭𝐮𝐧𝐢𝐭𝐲: 𝐏𝐨𝐢𝐧𝐭-𝐨𝐟-𝐜𝐚𝐫𝐞 𝐃𝐢𝐚𝐠𝐧𝐨𝐬𝐭𝐢𝐜𝐬 Point-of-care (POC) testing is performed at or near the site of patient care. Improvements in the level of accuracy of tests and the increasing number of diagnostic tests for different conditions are the major factors that are providing a niche market opportunity for POC devices in respiratory diagnostics. 𝐓𝐡𝐞 𝐜𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬 𝐟𝐞𝐚𝐭𝐮𝐫𝐞𝐝 𝐢𝐧 𝐭𝐡𝐢𝐬 𝐫𝐞𝐩𝐨𝐫𝐭 𝐢𝐧𝐜𝐥𝐮𝐝𝐞 Philips Medtronic ResMed Masimo Fisher & Paykel Healthcare Drägerwerk AG & Co. KGaA Getinge Nihon Kohden America GE HealthCare Vyaire Medical Baxter International Inc. AdaptHealth Rotech Healthcare Teleflex Air Liquide Invacare Corporation ICU Medical Hamilton Medical Apex Medical LLC Medline Industries, LP Nonin Medical, Inc. Allied Medical Limited Drive DeVilbiss Healthcare OMRON Healthcare, Inc.

The global Smart Implantable Pumps market was valued at US$ 1195.8 million in 2023 and is anticipated to reach US$ 1681.2 million by 2030 witnessing a CAGR of 4.5% during the forecast period 20242030. #SmartImplantablePumps #HealthcareTechnology #ChronicDiseaseManagement #MinimallyInvasiveTreatments #HealthcareInnovation #MarketGrowth #HealthcareTrends #MedicalDevices #PatientCare #GlobalMarket